Dysgerminoma: The role of conservative surgery

Gynecologic Oncology

Volumn 63, Issue 3, 1996, Pages 352-357

  Casey, A Catherine ^a   Bhodauria, Sushma ^a   Shapter, Anne ^a   Nieberg, Roberta ^a   Berek, Jonathan S ^a   Farias Eisner, Robin ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADOLESCENT; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DYSGERMINOMA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; OVARIECTOMY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SURGICAL APPROACH;

EID: 0030561476     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0335     Document Type: Article

References (25)

1. 1. Pedowitz, P., Flemus, L. B., and Grayzel, D. M. Dysgerminoma of the ovary: Prognosis and treatment, Am. J. Obstet. Gynecol. 70, 1284-1297 (1955).
2. 2. Malkasian, G. D., and Symmonds, R. E. Treatment of the unilateral encapsulated ovarian disgerminoma, Am. J. Obstet. Gynecol. 90, 379-382 (1964).
3. 3. Wider, J. A., and O'Leary, J. A. Dysgerminoma: A clinical review, Obstet. Gynecol. 31, 560-565 (1968).
4. 4. Krepart, G., Smith, J. P., Rutledge, F., and Delclos, L. The treatment for dysgerminoma of the ovary, Cancer 41, 986-990 (1978).
5. 5. Asadourian, L. A., and Taylor, H. B. Dysgerminoma: An analysis of 105 cases, Obstet. Gynecol. 33, 370-379 (1969).
6. 6. Freel, J. H., Cassir, J. F., Pierce, V. K., Woodruff, J., and Lewis, J. L., Jr. Dysgerminoma of the ovary, Cancer 43, 798-805 (1979).
7. 7. Gordon, A., Lipton, D., and Woodruff, J. D. Dysgerminoma: A review of 158 cases from the Emil Novak ovarian tumor registry, Obstet. Gynecol. 58, 497-504 (1981).
8. 8. De Palo, G., Pilotti, S., Kenda, R., Ratti, E., Musumeci, R., Mangioni, C., Di Re, F., Lattuada, A., Umberta, C., Cefis, F., Recanatini, L., Carinelli, S., and Rossi, G. Natural history of dysgerminoma, Am. J. Obstet. Gynecol. 143, 799-807 (1982).
9. 9. LaPolla, J. P., Benda, J., Vigliotti, A. P., and Anderson, B. Dysgerminoma of the ovary, Obstet. Gynecol. 69, 859-864 (1987).
10. 10. Thomas, G. M., Dembo, A. J., Hacker, N. F., and DePetrillo, A. D. Current therapy for dysgerminoma of the ovary, Obstet. Gynecol. 70, 268-275 (1987).
11. 11. Gallion, H. H., van Nagell, J. R., Donaldson, E. S., and Powell, D. E. Ovarian dysgerminoma: Report of seven cases and review of the literature, Am. J. Obstet. Gynecol. 158, 591-595 (1988).
12. 12. Jacobs, A. J., Harris, M., Deppe, G., DasGupta, I., and Cohen, C. J. Treatment of recurrent and persistant germ cell tumors with cisplatin, vinblastine and bleomycin, Obstet. Gynecol. 59, 129-132 (1982).
13. 13. Micha, J. P., Kucera, P. R., Berman, M. L., Romansky, S., Flamm, M., Reynolds, J., and DiSaia, P. J. Malignant ovarian germ cell tumors: A review of thirty-six cases, Am. J. Obstet. Gynecol. 152, 842-846 (1985).
14. 14. Gershenson, D. M., Wharton, J. T., Kline, R. C., Larson, D. M., Kavanagh, J. J., and Rutledge, F. N. Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma, Cancer 58, 2594-2599 (1986).
15. 15. Gershenson, D. M., Morris, M., Cangir, A., Kavanagh, J. J., Stringer, C. A., Edwards, C. L., Silva, E. G., and Wharton, J. T. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin, J. Clin. Oncol. 8, 715-720 (1990).
16. 16. Williams, S. D., Blessing, J. A., Hatch, K. D., and Homesley, H. D. Chemotherapy of advanced dysgerminoma: Trials of the Gynecologic Oncology Group, J. Clin. Oncol. 9, 1950-1955 (1991).
17. 17. Schellhas, H. F. Malignant potential of the dysgenetic gonad, I, Obstet. Gynecol. 44, 298-309 (1974).
18. 18. Steller, M. A., Soper, J. T., Szpak, C. A., Lanman, J. T., and Clark-Pearson, D. L. The importance of determining karyotype in premenarchal females with gonadal dysgerminoma, Cancer 67, 1084-1090 (1991).
19. 19. Mitchel et al.
20. 20. Cohen, S. M., and Goldsmith, M. A. Prolonged chemotherapeutic remission of metastatic ovarian dysgerminoma: Report of a case, Gynecol. Oncol. 5, 299-304 (1977).
21. 21. Weinblatt, M. E., and Ortega, J. A. Treatment of children with dysgerminoma of the ovary, Cancer 49, 2608-2611 (1982).
22. 22. Williams, S. D., Birch, R., Einhorn, L. H., Irwin, L., Greco, F. A., and Loehrer, P. J. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide, N. Engl. J. Med. 316, 1435-1440 (1987).
23. 23. Gershenson, D. M. Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors, J. Clin. Oncol. 6, 270-275 (1988).
24. 24. Schwartz, P. E., and Morris, J. M. Serum lactic dehydrogenase: A tumor marker for dysgerminoma, Obstet. Gynecol. 72, 511-515 (1988).
25. 25. Pressley, R. H., Muntz, H. G., Falkenberry, S., and Rice, L. W. Serum lactic dehydrogenase as a tumor marker in dysgerminoma, Gynecol. Oncol. 44, 281-283 (1992).